AGE |
Advanced glycation end products |
AMP |
Antimicrobial peptide |
BCL6 |
B-cell lymphoma-6 protein |
DNA |
Deoxyribonucleic acid |
ECM |
Extracellular matrix |
EMA |
European Medicines Agency |
FDA |
US Food and Drug Administration |
GRAS |
Generally recognized as safe |
HA |
Hyaluronic acid |
HCA2 |
Hydroxycarboxylic acid receptor 2 |
IL |
Interleukins |
MHC |
Major histocompatibility complex |
MMP |
Matrix metalloproteinases |
MRC-1 |
Mannose receptor C-1 |
mRNA |
Messenger ribonucleic acid |
NAD+
|
Nicotinamide adenine dinucleotide (oxidized) |
NADH |
Nicotinamide adenine dinucleotide (reduced) |
NADPH |
Nicotinamide adenine dinucleotide phosphate |
NO |
Nitric oxide |
NOS |
Nitric oxide synthase |
PARP |
Poly-(ADP-ribose) polymerase |
PGE2 |
Prostaglandin E2
|
ROS |
Reactive oxygen species |
SASP |
Senescence-associated secretory phenotype |
SIRT |
Sirtuin |
TNF-α Tumour necrosis factor alpha |
US |
United States of America |
UV |
Ultraviolet |